- Home
- NEOV vs XBIT Comparison
NEOV vs XBIT Comparison
Compare NEOV & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- XBIT
- Stock Information
- Founded
- NEOV 2018
- XBIT 2005
- Country
- NEOV United States
- XBIT United States
- Employees
- NEOV N/A
- XBIT N/A
- Industry
- NEOV Industrial Machinery/Components
- XBIT Pharmaceuticals and Biotechnology
- Sector
- NEOV Miscellaneous
- XBIT Health Care
- Exchange
- NEOV Nasdaq
- XBIT Nasdaq
- Market Cap
- NEOV 181.8M
- XBIT 194.5M
- IPO Year
- NEOV N/A
- XBIT 2015
- Fundamental
- Price
- NEOV $3.27
- XBIT $3.38
- Analyst Decision
- NEOV Strong Buy
- XBIT
- Analyst Count
- NEOV 1
- XBIT 0
- Target Price
- NEOV $7.50
- XBIT N/A
- AVG Volume (30 Days)
- NEOV 314.7K
- XBIT 52.0K
- Earning Date
- NEOV 02-11-2025
- XBIT 03-14-2025
- Dividend Yield
- NEOV N/A
- XBIT N/A
- EPS Growth
- NEOV N/A
- XBIT N/A
- EPS
- NEOV N/A
- XBIT N/A
- Revenue
- NEOV $2,471,178.00
- XBIT N/A
- Revenue This Year
- NEOV $85.10
- XBIT N/A
- Revenue Next Year
- NEOV $281.25
- XBIT N/A
- P/E Ratio
- NEOV N/A
- XBIT N/A
- Revenue Growth
- NEOV N/A
- XBIT N/A
- 52 Week Low
- NEOV $0.63
- XBIT $3.25
- 52 Week High
- NEOV $6.11
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- NEOV 37.47
- XBIT 26.88
- Support Level
- NEOV $3.27
- XBIT $3.40
- Resistance Level
- NEOV $3.85
- XBIT $3.69
- Average True Range (ATR)
- NEOV 0.33
- XBIT 0.20
- MACD
- NEOV -0.04
- XBIT 0.05
- Stochastic Oscillator
- NEOV 13.12
- XBIT 3.85
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.